P
WST icon

Palladiem’s West Pharmaceutical WST Stock Holding History

Palladiem’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$12K Hold
218
– – 0.02% 88
2015
Q2 		$13K Hold
218
– – 0.01% 121
2015
Q1 		$13K Hold
218
– – 0.01% 110
2014
Q4 		$12K Buy
+218
New +$10.9K 0.01% 123

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Palladiem's WST Position: Q3 2015 in Review

Palladiem held its West Pharmaceutical (WST) position steady in Q3 2015 at 218 shares worth $12K. The position accounts for 0.02% of the portfolio, ranked #88.

Palladiem first reported a position in WST in Q4 2014 and has held it in 4 quarters since. The position peaked at $13K in Q2 2015. 247 funds tracked by Wall St. Rank hold WST as of Q3 2015.

  • Palladiem held 218 shares of West Pharmaceutical worth $12K as of Q3 2015.
  • Palladiem left its West Pharmaceutical share count unchanged in Q3 2015.
  • West Pharmaceutical made up 0.02% of Palladiem's portfolio in Q3 2015, its #88 holding.
  • Palladiem first reported a position in West Pharmaceutical in Q4 2014 and has held it in 4 quarters since.
  • Palladiem's West Pharmaceutical position peaked at $13K in Q2 2015.
  • 247 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2015.

Based on Palladiem's 13F filing for Q3 2015, filed 29 Oct 2015.